Paper33609656
Pyridones in drug discovery: Recent advances.
Zhang Y and 1 other. Bioorg Med Chem Lett, 2021. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Pyridones in drug discovery: Recent advances. Papers, record 33609656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33609656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Discovery | Major topic |
| Pyridones | Major topic |
| Chemistry, Pharmaceutical | |
| Molecular Structure |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42742168 | Phosphine-mediated azine C-H couplings with water and ammonia. | Nature | 2026 | https://conductscience.org/library/papers/42742168 | PubMed |
| 42663793 | Genome mining guided identification of new furo[3,2-c]pyridones phaeopyridones A-C from the endophytic fungus Phaeobotryon negundinis 12020. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42663793 | PubMed |
| 42568152 | Hydroamination of Dehydroalanine With Deuterium Incorporation to Access Unnatural 2- and 4-Pyridonyl α-Amino Acids: Evaluation of Their Antibacterial, Antifungal, and Immunomodulatory Activities. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42568152 | PubMed |
| 42446695 | Recent advances in piperidones as privileged scaffolds for drug discovery and development. | Med Chem Res | 2026 | https://conductscience.org/library/papers/42446695 | PubMed |
| 42334509 | Novel bioactive compounds from marine-derived endosymbiotic Penicillium fungi reported during 2020-2025. | Nat Prod Bioprospect | 2026 | https://conductscience.org/library/papers/42334509 | PubMed |
| 42251670 | Energy-Transfer Catalysis Enables the Birch-Type Reduction of 2-Pyridones. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42251670 | PubMed |
| 42028031 | Phenotypic screening of human iPSC-derived neurons identifies thienopyridones as neuritogenic small molecules. | iScience | 2026 | https://conductscience.org/library/papers/42028031 | PubMed |
| 41103934 | Novel 2-substituted benzothiazole derivatives: synthesis, in vitro and in silico evaluations as potential anticancer agents. | RSC Adv | 2025 | https://conductscience.org/library/papers/41103934 | PubMed |
| 40881991 | Postoperative Adhesions: Current Research on Mechanisms, Therapeutics and Preventative Measures. | Biomed Mater Devices | 2025 | https://conductscience.org/library/papers/40881991 | PubMed |
| 40593433 | Structural characteristics and SARs of EZH2 inhibitors. | Mol Divers | 2026 | https://conductscience.org/library/papers/40593433 | PubMed |
| 40236529 | Comparative Hydrophobicity, Solubility, and Metabolic Stability of 4(1H)-Pyridones, 4(1H)-Quinolones, and 9(10H)-Acridones. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/40236529 | PubMed |
| 39950275 | Unlocking the Biological Potential of 2-Pyridones: Synthesis, Antioxidant and Antimicrobial Activity of N-Phenacylated 5/6-Chloro-2-pyridones. | Med Chem | 2026 | https://conductscience.org/library/papers/39950275 | PubMed |
| 39606936 | Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1H)-one derivatives as antioxidant and α-amylase inhibitors. | Future Med Chem | 2024 | https://conductscience.org/library/papers/39606936 | PubMed |
| 39598663 | Direct Synthesis of Benzhydryl-Functionalized 3,4-Dihydropyridin-2-ones from 2-Pyridones and Their Use in the Formation of Bridged δ-Lactams. | Molecules | 2024 | https://conductscience.org/library/papers/39598663 | PubMed |
| 39351407 | Recent trends for chemoselectivity modulation in one-pot organic transformations. | RSC Adv | 2024 | https://conductscience.org/library/papers/39351407 | PubMed |
| 39135973 | Crystal structure, spectroscopy, DFT, and thermal studies of 3-cyano-2(1H)-pyridones as potential anticancer agents. | RSC Adv | 2024 | https://conductscience.org/library/papers/39135973 | PubMed |
| 39009909 | Synthesis, characterization and bioactivity of new pyridine-2(H)-one, nicotinonitrile, and furo[2,3-b]pyridine derivatives. | Mol Divers | 2025 | https://conductscience.org/library/papers/39009909 | PubMed |
| 38647989 | Reaction strategies for the meta-selective functionalization of pyridine through dearomatization. | Mol Divers | 2025 | https://conductscience.org/library/papers/38647989 | PubMed |
| 38577370 | The "cesium effect" magnified: exceptional chemoselectivity in cesium ion mediated nucleophilic reactions. | Chem Sci | 2024 | https://conductscience.org/library/papers/38577370 | PubMed |
| 38530788 | Direct C-H Hydroxylation of N-Heteroarenes and Benzenes via Base-Catalyzed Halogen Transfer. | J Am Chem Soc | 2024 | https://conductscience.org/library/papers/38530788 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33609656
GET https://conductscience.org/api/papers/v1/33609656/cited_by?page=2